Print

Urovalve's CEO Dr. Harvey Homan Appointed to National Institutes of Health (NIH)'s Center for Scientific Review (CSR)  
3/15/2010 10:27:14 AM

NEWARK, N.J.--(BUSINESS WIRE)--Urovalve, a medical device company focused on creating products for urinary flow and control, announced today that its president and CEO, Harvey Homan, Ph.D., has been appointed to the National Institutes of Health’s Center for Scientific Review advisory panel for Urology and Small Business.